LIPO
Lipella Pharmaceuticals
LIPO
LIPO
Delisted
LIPO was delisted on the 18th of June, 2025.
7 hedge funds and large institutions have $377K invested in Lipella Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and closing their positions.
Holders
7
Holders Change
+3
Holders Change %
+75%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
3
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $275K | 269,829 | +269,829 | New |
|
2
Geode Capital Management
Boston,
Massachusetts
| $42.9K | 42,090 | +42,090 | New |
|
3
Vanguard Group
Malvern,
Pennsylvania
| $35.2K | 34,520 | – | – |
|
4
Two Sigma Investments
New York
| $16.2K | 15,865 | +15,865 | New |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $7.06K | 6,919 | +1,999 | +41% |
|
6
UBS Group
Zurich,
Switzerland
| $776 | 761 | +589 | +342% |
|
7
Wells Fargo
San Francisco,
California
| $30 | 29 | +1 | +4% |
|
|
CFGS
8
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|